Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

ClinicalTrials.gov ID: NCT05461105

Public ClinicalTrials.gov record NCT05461105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ALTITUDE NASH: A Phase 2, Randomized, Multi-Center, Open-Label Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With Nonalcoholic Steatohepatitis Stage 3 Fibrosis

Study identification

NCT ID
NCT05461105
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hepion Pharmaceuticals, Inc.
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • rencofilstat, 75 mg Drug
  • rencofilstat, 150mg Drug
  • rencofilstat, 225 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 14, 2022
Primary completion
Apr 14, 2023
Completion
Jul 6, 2023
Last update posted
Jun 12, 2024

2022 – 2023

United States locations

U.S. sites
20
U.S. states
7
U.S. cities
19
Facility City State ZIP Site status
Arizona Liver Health-Chandler Chandler Arizona 85224
Arizona Liver Health-Glendale Peoria Arizona 85381
Adobe Clinical Research, LLC Tucson Arizona 85712
Arizona Liver Health-Tucson Tucson Arizona 85712
Velocity Clinical Research-Chula Vista Chula Vista California 91911
Velocity Clinical Research-San Diego La Mesa California 91942
Synergy Healthcare, LLC Bradenton Florida 34208
Covenant Metabolic Specialists-Fort Myers Fort Myers Florida 33912
Evolution Clinical Trials, Inc. Hialeah Gardens Florida 33016
Progressive Medical Research Port Orange Florida 32127
Covenant Metabolic Specialists-Sarasota Sarasota Florida 34240
Clinical Research Institute of Michigan Chesterfield Michigan 48047
Coastal Reseach Institute Fayetteville North Carolina 28304
Optimed Research Columbus Ohio 43235
Clinical Research Institute of Ohio Westlake Ohio 44145
Pinnacle Clinical Research-Austin Austin Texas 78757
Apex Mobile Clinical Research Bellaire Texas 77401
South Texas Research Institute Edinburg Texas 78539
Pinnacle Clinical Research-Georgetown Georgetown Texas 78626
Pinnacle Clinical Research-San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05461105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05461105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →